Hot Earnings: BioMarin Pharmaceutical, Bazaarvoice Inc, Century Aluminum , Corelogic Inc.

Lakeway, NY -- (SBWIRE) -- 02/22/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) closed at $53.27. The Company announced financial results for the fourth quarter. GAAP net loss was $53.0 million or $0.43 per share for the fourth quarter of 2012 compared to GAAP net loss of $26.7 million or $0.23 per share in the fourth quarter of 2011. Non-GAAP adjusted EBITDA was a loss of $15.5 million for the fourth quarter of 2012 compared to non-GAAP adjusted EBITDA loss of $3.0 million for the fourth quarter of 2011.

Is BMRN a Still a Buy after the Solid momentum? Let’s Find out Here

Bazaarvoice Inc. (NASDAQ:BV) soared 3.12% to $6.95 after market trading hours. The Company reported third quarter results. The revenue was $42.7 million, up 55% from the third quarter of 2012. The Adjusted EBITDA was a loss of $5.5 million, compared to a loss of $3.0 million for the third quarter of 2012. The GAAP net loss was $10.8 million compared to GAAP net loss of $6.6 million for the third quarter of 2012. GAAP net loss per share was $0.15 compared to $0.34 for the third quarter of 2012.

Is BV a Strong Buying Opportunity After The Recent Slump? Find out Here

Century Aluminum Co. (NASDAQ:CENX) closed at $8.83. The Company reported net loss of $6.9 million or $0.08 per share in the fourth quarter of 2012 compared to net loss of $31.1 million or $0.35 per share in the fourth quarter of 2011. Financial results were positively impacted by an unrealized net gain on forward contracts of $2.4 million primarily related to the mark to market of aluminum price protection options. Sales for the fourth quarter of 2012 were $317.7 million compared to $318.2 million in the fourth quarter of 2011.

Should CENX Buy After The Recent Movement? Let’s Find out Here

Corelogic Inc. (NYSE:CLGX) closed at $26.99. The Company reported fourth quarter net income of $14.7 million or $0.15 per share compared to loss of $22.2 million or $0.21 per share in the prior year period. The adjusted earnings for the quarter were $0.36 per share versus $0.15 per share last year. The revenues increased 18.8% to $410.4 million. Analysts polled by Thomson Reuters expected the company to earn $0.34 per share on revenues of $389.01 million for the quarter.

Is CLGX a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.